- Home
- STM vs BNTX Comparison
STM vs BNTX Comparison
Compare STM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STM
- BNTX
- Stock Information
- Founded
- STM 1987
- BNTX 2008
- Country
- STM Switzerland
- BNTX Germany
- Employees
- STM N/A
- BNTX N/A
- Industry
- STM Semiconductors
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STM Technology
- BNTX Health Care
- Exchange
- STM Nasdaq
- BNTX Nasdaq
- Market Cap
- STM 24.4B
- BNTX 23.9B
- IPO Year
- STM 1994
- BNTX 2019
- Fundamental
- Price
- STM $25.71
- BNTX $114.00
- Analyst Decision
- STM Buy
- BNTX Strong Buy
- Analyst Count
- STM 8
- BNTX 15
- Target Price
- STM $37.63
- BNTX $143.50
- AVG Volume (30 Days)
- STM 5.5M
- BNTX 659.5K
- Earning Date
- STM 01-23-2025
- BNTX 11-04-2024
- Dividend Yield
- STM 1.40%
- BNTX N/A
- EPS Growth
- STM N/A
- BNTX N/A
- EPS
- STM 2.27
- BNTX N/A
- Revenue
- STM $14,229,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- STM N/A
- BNTX N/A
- Revenue Next Year
- STM $8.51
- BNTX N/A
- P/E Ratio
- STM $10.90
- BNTX N/A
- Revenue Growth
- STM N/A
- BNTX N/A
- 52 Week Low
- STM $23.96
- BNTX $76.53
- 52 Week High
- STM $50.94
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- STM 47.37
- BNTX 48.71
- Support Level
- STM $24.15
- BNTX $109.52
- Resistance Level
- STM $26.59
- BNTX $115.34
- Average True Range (ATR)
- STM 0.60
- BNTX 4.24
- MACD
- STM -0.00
- BNTX -0.72
- Stochastic Oscillator
- STM 47.93
- BNTX 27.24
About STM STMicroelectronics N.V.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.